Compounds of formula (I):
wherein variable groups are defined within; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are described.
本文描述了式(I)的化合物,其中变量基团在内部定义;它们在抑制11βH
SD1中的应用,制造这些化合物的过程以及包含它们的制药组合物。